5:43 AM
 | 
Jan 03, 2019
 |  BC Innovations  |  Distillery Therapeutics

Endocrine/metabolic

INDICATION: Obesity

Cell culture, mouse and non-human primate (NHP) studies suggest inhibiting the GIP receptor alone or in combination with GLP-1R agonists could help treat obesity. In a mouse model of diet-induced obesity, a mouse anti-GIP receptor mAb increased glucose tolerance compared with vehicle. Also in the model, the mAb...

Read the full 222 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >